|
Originally published In Press as doi:10.1074/jbc.M002460200 on April 25, 2000
J. Biol. Chem., Vol. 275, Issue 27, 20588-20596, July 7, 2000
Type II cAMP-dependent Protein Kinase-deficient
Drosophila Are Viable but Show Developmental, Circadian,
and Drug Response Phenotypes*
Sang Ki
Park,
Stacey A.
Sedore,
Claire
Cronmiller, and
Jay
Hirsh
From the Department of Biology, University of Virginia,
Charlottesville, Virginia 22903
Received for publication, March 23, 2000
 |
ABSTRACT |
We identified a unique type II
cAMP-dependent protein kinase regulatory subunit (PKA-RII)
gene in Drosophila melanogaster and a severely hypomorphic
if not null mutation, pka-RIIEP(2)2162.
Extracts from pka- RIIEP(2)2162 flies selectively
lack RII-specific autophosphorylation activity and show significantly
reduced cAMP binding activity, attributable to the loss of functional
PKA-RII. pka-RIIEP(2)2162 shows 2-fold increased
basal PKA activity and ~40% of normal cAMP-inducible PKA activity.
pka-RIIEP(2)2162 is fully viable but displays
abnormalities of ovarian development and multiple behavioral phenotypes
including arrhythmic circadian locomotor activity, decreased
sensitivity to ethanol and cocaine, and a lack of sensitization to
repeated cocaine exposures. These findings implicate type II PKA
activity in these processes in Drosophila and imply a
common role for PKA signaling in regulating responsiveness to cocaine
and alcohol.
 |
INTRODUCTION |
cAMP is a widely used second messenger that participates in a
plethora of cellular, neural, and developmental processes. Neural functions of cAMP signaling include roles in a number of plastic responses, including learning and memory (1-6), synaptic transmission (7, 8), circadian rhythmicity (9), modulation of photoreceptor responses to light (10), and modulation of responses to alcohol (11,
12) and other drugs of abuse (13, 14). A key intermediate in cAMP
signaling is cAMP-dependent protein kinase,
PKA1 (15). PKA acts as a key
sensor of cellular cAMP levels and mediates the flow of signals to
downstream effector pathways by phosphorylating their targets. PKA is a
heterotetrameric holoenzyme composed of two catalytic subunits
(C2) and a homodimer of regulatory subunits
(R2). The R2 homodimer not only inhibits the
catalytic activity of the C subunits but also stabilizes C subunits
against proteolytic degradation in the PKA heterotetramer. Binding of cAMP to the R subunits of the holoenzyme results in dissociation of R
and C subunits, which are then catalytically active. These general
features of PKA signaling are shared by most eukaryotic organisms.
PKA can be formed from several types of C and R subunits that can endow
the PKA heterodimer with different signaling and subcellular localization properties. The three subtypes of C subunits (C , C ,
and C ) have virtually identical kinetic and physiological properties
(15). By contrast, the different R subunit types, RI and RII, exhibit
distinct cAMP binding affinities and are differentially localized in
cells, leading to PKA holoenzymes termed PKAI or PKAII, respectively.
PKAI holoenzyme is predominantly cytoplasmic, whereas the majority of
PKAII associates with cellular structures and organelles (16). This
subcellular localization is largely mediated by anchoring of RII
subunits to protein kinase A-anchoring proteins (AKAPs). RII subunits
bind to AKAPs with nanomolar affinity (17), whereas RI subunits only
bind weakly to AKAPs (18). Adding to this complexity, higher
vertebrates express two types of RI and RII genes that have different
spatial patterns of expression (19).
In Drosophila, genetic and molecular approaches have led to
the identification of a type I R subunit (pka-RI) and three
genes for catalytic subunit isoforms, pka-C1 (also known as
DC0), pka-C2, and pka-C3 (20). Both RI
and RII PKA subunits have also been detected biochemically. PKA-RI is
detectable during larval stages and early and mid-pupation (21),
although its transcripts can be detected in the adult mushroom bodies
of the brain (5). Consistent with this expression pattern, a
pka-RI mutant shows learning defects (5). PKA-RII is
expressed much more abundantly than PKA-RI in adult
Drosophila (21), and its expression is largely restricted to
the nervous system, where it is also preferentially expressed in
mushroom bodies (22). The Drosophila gene encoding PKA-RII
has not been previously identified.
From the analysis of pka-C1 and other cAMP signaling genes
such as amnesiac (amn, a PACAP-like adenylate
cyclase-activating peptide), pka-RI (5), rutabaga
(rut, Ca2+/CaM-responsive adenylate cyclase),
and dunce (dnc, cAMP phosphodiesterase), there is
functional evidence for the involvement of cAMP signaling in learning
and memory (3), ovarian development (23), maintenance of circadian
locomotor rhythmicity (9), and modulation of the sensitivity to ethanol
intoxication (11) in Drosophila. In addition, PKA signaling
functions in the widely used hedgehog signaling pathway
(reviewed in Ref. 24).
Despite the aforementioned analyses, separable roles for PKAI
versus PKAII signaling have been difficult to discern. In
mouse, knockout of the RII gene leads to
experience-dependent locomotor defects and
hypersensitization to repeated amphetamine exposures (14). These
phenotypes could be due to the loss of the RII subunit, but there
are compensatory increases in other RI and RII subunits that could also
explain the effects. Similar compensation is seen in RI -deficient
mice (25). In flies, the pka-RI mutant shows a learning
deficit, but this may not be the full extent of pka-RI
functions, since this mutant retains significant PKA-RI expression
(5).
Here we identify the Drosophila pka-RII gene and mutations
that virtually abolish its expression yet are homozygous-viable. We
used these PKAII-deficient mutants to analyze the involvement of PKAII
in various biological processes in Drosophila.
 |
EXPERIMENTAL PROCEDURES |
Fly Strains--
The EP(2)2162 (26) line was obtained from the
Berkeley Drosophila Genome Project (BDGP). For genetic
background controls, randomly selected EP lines (EP(2)0844,
EP(X)1529, and EP(X)1192) were used, as well as
w1118.
Autophosphorylation Analysis--
Autophosphorylation analysis
was carried out as described in Foster et al. (21) with
modifications. Briefly, protein extracts were prepared from whole flies
by homogenizing the frozen flies in Buffer A (5 mM EDTA, 50 mM Tris, pH 7.5) and subsequently centrifuging at
10,000 × g for 30 min. The protein concentration of
supernatants was determined by the Bradford method. A volume of extract
containing 30 µg of protein was incubated with 0.5 µCi of
[ -32P]ATP (NEN Life Science Products) without
additional cold ATP in the presence or absence of 10 µM
cAMP in a total volume of 20 µl of Buffer B (10 mM
-mercaptoethanol, 10 mM MgCl2, 1 mM EDTA, 50 mM Tris, pH 7.5) for 10 min on ice.
The reaction was stopped by addition of 20 µl of 2× SDS gel loading
buffer. 20 µl of assay mixture was separated on a 10%
SDS-polyacrylamide gel. The gel was fixed, dried, and autoradiographed.
Western Blotting--
A volume of whole fly extract containing
15 µg of protein from each genotype was separated in an SDS-10%
polyacrylamide gel and transferred to the nitrocellulose membrane. The
blot was blocked with 3% dried nonfat milk in TBS (25 mM
Tris, 137 mM NaCl, 2 mM KCl, pH 8.0) for 30 min
and incubated with anti-RII antiserum (generously provided by Dr. D. Kalderon) for 2 h. After washing three times with TBS, the
membrane was incubated with horseradish peroxidase-conjugated
anti-rabbit goat IgG (Roche Molecular Biochemicals) for 2 h at
room temperature and then washed with TBS three times. Immunoreactivity
was visualized using the ECL system (Amersham Pharmacia Biotech)
following the manufacturer's instructions. Kodak Image Station CF440
(Eastman Kodak Co.) was used to develop the image and to analyze the
relative density of signals.
cAMP Binding Assay--
cAMP binding activity was measured by
the method described in Kumon et al. (27). A volume of
extract containing 30 µg of protein was incubated with 1 µCi of
3',5'-(2',8'-3H]cAMP (ICN, Costa Mesa, CA) in a total
volume of 100 µl of Buffer C (50 mM sodium acetate, pH
4.5, 10 mM MgCl2) for 2 h on ice. Reaction
mixtures were subsequently filtered through nitrocellulose filters
(Millipore, Bedford, MA), and the filters were washed 10 times with
Buffer C. The radioactivities of dried nitrocellulose filters were measured.
PKA Activity Assay--
A volume of extract containing 30 µg
of protein was incubated with 50 µM Kemptide,
Leu-Arg-Arg-Ala-Ser-Leu-Gly (Life Technologies, Inc.), in a total
volume of 40 µl of Buffer D (10 mM MgCl2, 0.1 mM ATP supplemented with 2 µCi of
[ -32P]ATP, 0.25 mg/ml bovine serum albumin, 50 mM Tris, pH 7.5) in the presence and/or absence of 10 µM cAMP and 1 µM of PKA
inhibitor-(6-22)-amide (Life Technologies, Inc.) for 5 min at
30 °C. Incorporation of phosphates to Kemptide was measured by
spotting the 20 µl of assay mixture onto Whatman P-81 paper and
subsequent washing with 1% phosphoric acid. Calculations of kinase
activity were based on the fraction inhibited by PKA
inhibitor-(6-22)-amide of total incorporation.
Ovary Staining--
To visualize nuclei,
4',6-diamidino-2-phenylindole staining was performed according to the
procedure of Ruohola et al. (48). To highlight cell outlines
and ring canals, rhodamine-conjugated phalloidin was added at the same
time as 4',6-diamidino-2-phenylindole.
Locomotor Activity Assay--
Male flies kept at 18 °C were
exposed to four cycles of 12-h light-12-h dark (LD, where zeitgeber
time 0 (ZT0) is lights on and 12 (ZT12) is light off), followed by
10-12 days in constant dark (DD) conditions in a locomotor activity
monitor (Trikinetics, Waltham, MA). Wild type and mutant flies were
tested simultaneously in a given experiment. The free running periods
of individual flies during DD were estimated by 2
periodogram analyses. Only data from flies that survived to the end of
the activity monitoring were used for further analyses.
Ethanol Sensitivity Assay--
Humidified ethanol vapor from a
50% ethanol:H2O (v/v) solution was pumped in parallel into
the top of two 50-ml tubes (Falcon, Lincoln Park, NJ). The tubes have a
number of small holes near the bottom to allow escape of vapors. 30 unanesthetized male flies were transferred to each tube, and the number
of flies immobilized on the bottom was counted every 5 min. In test
runs, the identical genotypes run in parallel showed no significant
difference in KO50, the time elapsed until 50% of flies
are immobilized to the bottom of a tube. Ethanol in the whole body
extracts was determined as described in Moore et al. (11). A
volume of extract containing 30 µg of protein was added to the 500 µl of alcohol reagent (Sigma) and incubated for 5 min at 37 °C,
and absorbance at 340 nm was measured. This was converted to ethanol
concentration by assaying ethanol standards provided by the manufacturer.
Cocaine Behavioral Assays--
Free-base cocaine was
administered as described previously (28). To evoke the substantial
initial response required for sensitization to the subsequent exposure
in pka- RIIEP(2)2162, higher doses of cocaine were
used. The second exposure was given 6 h after the first exposure.
Reversion Analysis--
To generate revertants, homozygous
pka- RIIEP(2)2162 flies were crossed with a
transposase line (y, w; Bc/CyO, 2-3) and the
male progeny with variegated eyes were collected and crossed with
y, w; Gla/CyO. White eye progeny were collected and crossed
individually with y, w; Gla/CyO and maintained as stocks.
Reversion was verified by polymerase chain reaction using the primers
(forward, 5'-GATGCGATCACCATAACGGCCCTTA-3',and reverse,
5'-GCGCGAAGCTGGAGTTAATTTGCG A-3') for the region that the P element had
been inserted. Subsequent nucleotide sequencing of polymerase chain
reaction products was carried out at the University of Virginia Health
Science Center Biomolecular Research Facility.
 |
RESULTS |
Molecular Characterization of a PKA-RII in Drosophila--
We
identified a cDNA encoding a Drosophila homolog of a
type II regulatory subunit of cAMP-dependent protein kinase
(PKA-RII) in the BDGP EST data base through BLAST searches based on the primary protein sequences of known PKA-RII proteins. These searches identified a single cDNA clone, LD44591, in BDGP cDNA
collections, which was subsequently sequenced in its entirety. The
cDNA encodes a deduced 42.7-kDa protein that retains significant
similarities to vertebrate PKA-RII proteins and the previously
identified Drosophila PKA-RI (Fig.
1). The most striking similarities are
observed in four cyclic nucleotide-binding domain signatures (residues
151-167, 187-204, 269-285, and 309-326) that form two
cAMP/cGMP-binding motifs (residues 124-239 and 242-362, indicated by
bars in Fig. 1). Also observed is a PKA autophosphorylation
site (residues 81-84, indicated by an asterisk in Fig. 1),
a unique feature of type II PKA regulatory subunits (29). It also
contains amino acid sequences that have been identified by peptide
sequencing from biochemically purified Drosophila PKA-RII
(30), indicated by dashes in Fig. 1).

View larger version (147K):
[in this window]
[in a new window]
|
Fig. 1.
Deduced amino acid sequence of
Drosophila PKA-RII aligned with known PKA-RII
proteins. Multiple protein sequence alignment for PKA-RII proteins
and a Drosophila PKA-RI was carried out using ClustalW. The
order of the sequences is based on the degree of similarity. Identical
amino acid residues are indicated by dark boxes, and the
residues that show similarity are indicated by shaded boxes.
Primary structure of PKA-RII was analyzed by scanning the sequence
against the pattern or profile entries in PROSITE and Swiss-Prot.
Bars indicate cyclic nucleotide-binding motifs, and
dashes indicate the peptide sequences of purified
Drosophila PKA-RII reported by Inoue and Yoshiokda (30). The
asterisk indicates the phosphorylation site for PKA.
|
|
Characterization of pka-RII Gene and Identification of a pka-RII
Mutant--
Genomic DNA sequences corresponding to
Drosophila PKA-RII cDNA were retrieved from the BDGP
genomic sequence data base, and polymerase chain reaction amplification
and subsequent DNA sequencing were carried out to determine the full
genomic DNA sequence. Ten exons are dispersed throughout the
>15-kilobase pair genomic region that is localized in the proximal
part of chromosome 2R in polytene region 46D1-46D2 (Fig.
2A). The data base searches
also led to the identification of a P insertion mutant, EP(2)2162,
inserted 89 base pairs upstream of the predicted transcription start
site corresponding to the sequence of LD44591 clone in a position that could block transcription of pka-RII. This insertion line is
homozygous-viable and fertile with no obvious behavioral or
developmental phenotypes.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
EP(2)2162 line is a PKA-RII mutant.
A, schematic diagram of the pka-RII gene.
Open boxes indicate exons for 5'- and 3'-untranslated
regions, and closed boxes represent exons for coding region.
pka-RIIEP(2)2162 has an EP element (26) inserted 89 base pairs upstream of the predicted transcription start site.
B, lack of PKA-RII autophosphorylation in the
pka-RIIEP(2)2162 extract. Whole fly extracts from
wild type (lanes 1 and 2) and
pka-RIIEP(2)2162 (lanes 3 and
4) flies were incubated with [ -32P]ATP in
the absence (lanes 1 and 3) or presence
(lanes 2 and 4) of cAMP (see "Experimental
Procedures"). PKA-RII (apparent mass of ~57 kDa, closed
arrow) is phosphorylated in a cAMP-sensitive manner. An ~70-kDa
band whose phosphorylation was not affected by cAMP is indicated by
open arrow. Molecular weight standards are indicated at the
left. C, reduced PKA-RII protein in the
pka-RIIEP(2)2162 extract. Whole fly extracts from
wild type (WT, lane 1) and
pka-RIIEP(2)2162 (lanes 2) flies were
analyzed by SDS-10% polyacrylamide gel electrophoresis and subsequent
Western blotting (see "Experimental Procedures"). The intensity of
the ~52-57-kDa PKA-RII bands (indicated by a closed
arrow) was reduced ~10-fold in the
pka-RIIEP(2)2162 extract. Molecular weight standards
are indicated at the left. D, decreased cAMP binding
activity in the pka-RIIEP(2)2162 extract. The cAMP
binding activity of three whole body extracts from
pka-RIIEP(2)2162 and wild type flies were assayed in
duplicate. The data points represent the mean ± S.E. ** indicates
statistical significance of the difference between genotypes determined
by one-tailed t test; p < 0.001.
|
|
To see the effect of this insertion on the expression of PKA-RII
protein, we tested the cAMP-sensitive autophosphorylation of PKA-RII in
whole fly extracts from wild type and EP(2)2162 lines (see
"Experimental Procedures"). ATP concentration in the reactions was
maintained low enough to allow predominant intramolecular RII
autophosphorylation that is blocked by cAMP addition and subsequent C
subunit dissociation (31). The autophosphorylation reaction leads to
the phosphorylation of ~57- and ~70-kDa proteins (Fig. 2B). The 57-kDa protein, which is phosphorylated in a
cAMP-sensitive manner, is reduced by >95% in the EP(2)2162 extracts
(Fig. 2B), and the phosphorylation of the 70-kDa protein is
increased about 2-fold. Given that cAMP-sensitive phosphorylation
occurs only on the PKA-RII that is electrophoretically determined to be
about ~52 kDa in its dephosphoform and ~57 kDa in its phosphoform
in Drosophila (21), this result indicates that
EP(2)2162 does not express a functional PKA-RII. Consistent with this,
by Western blotting analysis (Fig. 2C), RII immunoreactivity
is reduced ~10-fold in EP(2)2162 extract. In addition, the EP(2)2162
extract contains significantly reduced cAMP binding activity (Fig.
2D) attributable to the absence of PKA-RII, a major cellular
cAMP-binding protein (32). Taken together, the EP element in EP(2)2162
disrupts the normal expression of PKA-RII causing a severe, if not
null, mutation of pka-RII, which we subsequently
refer to as pka-RIIEP(2)2162. Since BLAST searches
against the Drosophila euchromatic genomic sequence data
base fail to show any additional pka-RII candidate genes
(data not shown), pka-RIIEP(2)2162 likely represents
the first animal in which PKAII activity is effectively eliminated.
We note that the PKA-RII cDNA encodes a deduced 42.7-kDa protein,
significantly smaller than the apparent size by electrophoretic mobility. A similar size discrepancy is observed in bovine PKA-RII, with deduced molecular mass of 45 kDa and apparent molecular mass of 58 kDa (33). This suggests that the structural properties of PKA-RII
proteins that induce the size discrepancy are conserved among these
diverse organisms.
pka-RIIEP(2)2162 Shows Altered PKA Activity--
In mouse,
loss of PKA regulatory subunits by genetic manipulations leads to
reduction of cAMP-inducible PKA activity mainly due to proteolytic
degradation of free PKA C subunits (25) and compensatory up-regulation
of the other PKA regulatory subunits (14). To assess the effect of
selective loss of PKA-RII on PKA activity in
pka-RIIEP(2)2162, we assayed PKA activity in the
total protein extracts from wild type and
pka-RIIEP(2)2162 whole flies (Fig.
3). In the absence of exogenous cAMP, the
low basal level of PKA activity is significantly increased in the pka-RIIEP(2)2162 extract (Fig. 3a),
consistent with an increase in free C subunits due to loss of RII
subunits. However, in the presence 10 µM cAMP, the
pka-RIIEP(2)2162 extract shows only ~40% of the
activity seen in wild type extract (Fig. 3b). The
inducibility of PKA activity by excess cAMP is ~70-fold in extracts
from wild type flies and ~12-fold in extracts from
pka-RIIEP(2)2162 with the reduction of cAMP action
attributable to the loss of this major cAMP signaling component.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Altered PKA activity of
pka-RIIEP(2)2162. PKA activities of the
whole fly extracts from pka-RIIEP(2)2162 and wild
type (WT) flies were measured in the absence (a)
and presence (b) of 10 µM cAMP. Three
homogenates of each genotype were assayed in duplicate. The data points
represent the mean ± S.E. The differences in PKA activities are
statistically significant between genotypes as determined by one-tailed
t test. *, p < 0.05, and **,
p < 0.001.
|
|
pka-RIIEP(2)2162 Affects Ovarian Development--
Since
defects in oogenesis have previously been reported for hypomorphic
pka-C1, a PKA catalytic subunit mutant (23, 34), we
investigated whether pka-RIIEP(2)2162 ovaries show
similar phenotypes (Fig. 4).
Approximately 43% (n = 150) of ovarioles from
pka-RIIEP(2)2162 flies show defects in follicle
formation and maturation. These defects include multinucleate nurse
cells, too many or too few nurse cells within a follicle, absence of
interfollicular stalks, and an abnormally large number of somatic
epithelial cells at the posterior end of the follicle. These phenotypes
are very similar, but not identical, to those seen in pka-C1
mutants. In pka-C1 ovaries, multinucleate nurse cells often
still contain the ring canal that would have connected the two nurse
cells (34), but in pka-RIIEP(2)2162 ovaries,
multinucleate cells (brackets, Fig. 4, b and
d) have no internal ring canals. Follicles with
multinucleate cells also seem to have fewer nurse cells than normal.
pka-RIIEP(2)2162 homozygotes also have large
follicles where double and triple the normal number of nurse cells is
observed, and often, these follicles are not separated from the next
follicle by an interfollicular stalk. The similarities between
pka-C1 and pka-RIIEP(2)2162 phenotypes
indicate that PKAII is a major contributor to PKA signaling during
ovarian development.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 4.
Abnormal ovarian development of
pka-RIIEP(2)2162. Ovarioles from wild
type (WT, a and c) and
pka-RIIEP(2)2162 (b and d)
females were stained with 4',6-diamidino-2-phenylindole
(DAPI, a and b) to visualize nuclei
and rhodamine-conjugated phalloidin (c and d) to
show cell outlines. The brackets in b and
d indicate an example of a multinucleate nurse cell.
|
|
pka-RIIEP(2)2162 Shows Arrhythmic Locomotor
Activity--
PKA is also involved in the maintenance of locomotor
circadian rhythmicity in Drosophila, functioning downstream
of the brain-based circadian pacemaker in an output pathway (9). We
analyzed locomotor rhythmicity of pka-RIIEP(2)2162.
About 42% of pka-RIIEP(2)2162 flies retain normal
circadian rhythmicity in constant environmental conditions (Fig.
5C), consistent with the
locomotor analyses of pka-C1 (9), a PKA catalytic
subunit mutant. pka-RIIEP(2)2162 entrains normally
to LD conditions but the rhythmicity rapidly dampens through following
DD conditions (Fig. 5B). In 42% of flies showing
rhythmicity, a normal period of ~23.7 h is observed. About 85% of
wild type and randomly selected EP lines consistently show normal
rhythmicity (Fig. 5, A and C, data not
shown).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 5.
Arrhythmic locomotor activity of
pka-RIIEP(2)2162. Locomotor activity of
individual flies kept at 18 °C was recorded for 4 days in light/dark
(LD) cycles followed by 10 days in constant darkness
(DD). Average locomotor activities of wild type
(WT, A) and pka-RIIEP(2)2162
(B) flies (n = 32 each) in the last day of
LD and the 5 subsequent days of DD are shown. Open and
solid bars indicate light and dark conditions, respectively.
The fractions of flies showing normal rhythmicity from the pool of
three independent experiments for each genotype are shown in
C. Statistical significance was determined by a
2 test; **, p < 0.001, n = 88 for wild type flies, and n = 105 for pka-RIIEP(2)2162.
|
|
pka-RIIEP(2)2162 Shows Altered Ethanol
Intoxication--
Functional evidence for the involvement of cAMP
signal transduction pathway in the ethanol intoxication in
Drosophila has been reported (11). Mutations in the gene
amn, which is thought to encode a positive regulator of cAMP
signaling, increase sensitivity to ethanol intoxication, as assayed by
increased rate of passing through an inebriometer. We devised a simple
apparatus that allows comparison of ethanol intoxication sensitivity of
two groups of flies in parallel, by measuring time for flies to fall to
the bottom of a tube through which humidified ethanol vapor is pumped (see "Experimental Procedures"). Multiple alleles of amn
were tested using this apparatus. Consistent with the previous report using the inebriometer (11), these amn alleles show shorter KO50 time than wild type or random EP lines (data not
shown). In contrast, pka-RIIEP(2)2162 shows robust
resistance to ethanol (Fig.
6A) with ~6 min longer KO50 time than wild type flies (Fig. 6B). To
verify that the observed phenotype is not due to the altered ethanol
permeability or metabolism rate, the amount of ethanol in the whole
body extracts of pka-RIIEP(2)2162 and wild type
lines was measured (see "Experimental Procedures"). There are no
significant differences in permeability and metabolism rates between
pka-RIIEP(2)2162 and wild type lines (data not
shown).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Decreased ethanol sensitivity of
pka-RIIEP(2)2162. 50%
ethanol:H2O was pumped into two tubes in parallel, each
contains 30 flies of each genotype in parallel, and the number of flies
immobilized at the bottom of the tubes were counted (see
"Experimental Procedures"). The data points represent the mean ± S.E. from three independent experiments. A, fraction of
flies immobilized to the bottom of tubes as a function of exposure
time. Open circles, wild type flies; closed
circles, pka-RIIEP(2)2162. B, time
(min) to immobilize 50% of flies (KO50) as a function of
genotypes. Asterisk indicates statistical significance
determined by one-tailed t test; p < 0.05, n = 3. WT, wild type.
|
|
pka-RIIEP(2)2162 Shows Altered Responsiveness to
Cocaine--
In vertebrates, PKA signaling is a key pathway modulating
responses to chronic administration of cocaine. We tested the
responsiveness of pka-RIIEP(2)2162 to cocaine, a
potent motor stimulant in flies (28). The response of
pka- RIIEP(2)2162 to the first dose of cocaine is
much lower than that of wild type flies and other randomly selected EP
lines (Fig. 7). Significantly higher
doses of cocaine (180-200 µg) are required to elicit substantial initial responses, which are induced at 75-90 µg of cocaine in wild
type lines. Furthermore, subsequent doses of cocaine failed to elicit
robust sensitization in pka-RIIEP(2)2162 flies,
whereas wild type flies show prominent sensitization (Fig. 7), measured
as an enhanced response to the second cocaine exposure.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 7.
Altered cocaine responsiveness of
pka-RIIEP(2)2162 to cocaine. Wild type
(WT) and pka-RIIEP(2)2162 male flies were
given two exposures to volatilized free-base cocaine at a 6-h interval,
and the behavioral responses were scored during the 5 min after
exposure with a behavioral scale described in McClung and Hirsh (28).
The fraction of flies showing behavioral scores of 5 (rapid twirling,
erratic jumping, or paralysis) or above is plotted for each exposure.
Error bars are standard deviations calculated for binomial
distributions. Significant differences in responses to the first
versus subsequent exposures were determined by the
2 test; *, p < 0.05, or **,
p < 0.01.
|
|
Reversion of pka-RIIEP(2)2162--
To ascertain that the
phenotypes reported are due to the EP(2)2162 element, multiple complete
and partial revertants were recovered by mobilizing the P element in
pka-RIIEP(2)2162 (see "Experimental
Procedures"). Phenotypes were analyzed against their background
strain (y,w) and parental strain
(pka-RIIEP(2)2162). Complete revertants,
pka-RIIrev7 and pka-RIIrev23,
show none of the behavioral and developmental defects that are observed
in pka-RIIEP(2)2162 (data not shown). Similarly,
imprecise excision of the P element resulting in deletion extending to
the pka-RII gene yields biochemical and behavioral
phenotypes indistinguishable from
pka-RIIEP(2)2162, indicating that
pka- RIIEP(2)2162 is a severely hypomorphic, if
not a null, mutant.
 |
DISCUSSION |
pka-RIIEP(2)2162 Is Deficient in PKAII--
Type II PKA is
the predominant isoform in adult Drosophila (21, 22), yet
the pka-RII gene has not been isolated previously. We detect
a unique pka-RII gene and a PKA-RII protein species that is
autophosphorylated in vitro in a cAMP-sensitive manner. We
have not detected other PKA-RII candidate genes in BDGP nucleotide sequence data base that represents most of Drosophila
euchromatic DNA sequence. A P element-induced mutation,
pka-RIIEP(2)2162, lacks at least 95% of
the cAMP-sensitive autophosphorylation activity, characteristic of RII.
Furthermore, deletions that extend into pka-RII as a result
of imprecise excision of this P element show phenotypes that are no
more severe than the initial mutant. Surprisingly, all of these mutants
show full viability. These mutants are the first animals in which PKAII
activity is essentially abolished, giving substrates for examining the
in vivo roles of PKAII signaling.
PKA activity in pka-RIIEP(2)2162 extracts shows
reduced cAMP-mediated inducibility, as would be expected for loss of
this major cAMP regulatory subunit. This reduction in cAMP inducibility
is due to two effects. First, these extracts show increased basal PKA activity measured in the absence of exogenous cAMP relative to wild
type, presumably due to an increase in free C subunits that are not
coupled with R subunits. Second, pka-RIIEP(2)2162
extracts show reduced PKA activity relative to wild type in the presence of saturating cAMP. In vertebrates, loss of R subunits leads
to destabilization of C subunits, making them more susceptible to
proteolytic degradation (14, 25). PKA activity at saturating cAMP
measures the total C subunit content, which is therefore reduced in
pka-RIIEP(2)2162.
Altered Cocaine Responsiveness of
pka-RIIEP(2)2162--
PKAII-deficient
pka-RIIEP(2)2162 flies show two defects in cocaine
responsiveness. First, they are very resistant to cocaine, requiring much higher doses than normal to stimulate locomotor responses. Second,
they are defective in sensitization, even when exposed to high enough
cocaine doses to yield behavioral responses sufficient to evoke
sensitization in wild type flies.
In vertebrates, stimulation of D1-like dopamine receptors subsequent to
cocaine exposure results in activation of
G-protein-dependent adenylate cyclase and PKA (reviewed in
Refs. 35 and 36), and pharmacological activation of adenylate cyclase
by cholera toxin produces an augmented behavioral response to an acute
injection of cocaine (37). Consistent with these effects, there is an increase in the basal activity of adenylate cyclase and PKA in the
nucleus accumbens of the forebrain after repeated cocaine administration (38). The PKA-mediated second messenger system regulates
the activity of immediate early genes, such as c-fos, via
cAMP-responsive element binding protein (reviewed in Ref. 13).
Additional PKA targets proposed to play a role in behavioral sensitization include
(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptors (39) and voltage-dependent sodium channels (36). All of these changes subsequent to psychostimulant exposure are interpreted as occurring in neurons postsynaptic to the dopamine neurons that project to this region, although G-protein signaling and
transmitter synthesis and release in the dopamine cells themselves can
also be altered by activation of dopamine autoreceptors (8, 40, 41).
The first phenotype, resistance to cocaine, is what would be expected
of a major disruption in cAMP signaling in postsynaptic neurons.
Mice lacking PKA-RII show normal responsiveness to amphetamine (14),
which targets the same amine transporters as cocaine. It is premature
to conclude that PKAII signaling is not involved in amphetamine
responsiveness in mice, since mice contain two each of the RI and RII
genes, and there is significant up-regulation of other R subunits in
compensation for the lack of RII during development (14).
The second phenotype seen in flies is a failure to sensitize to
repeated cocaine exposures. In flies, sensitization to cocaine can be
blocked by ectopic G-protein expression in dopamine and serotonin
neurons in the central nervous system, indicating a crucial role for
these neurons and this signaling pathway in sensitization (42).
However, sensitization results in enhanced nerve cord responses to
dopamine agonists (43), most simply interpreted as enhanced
responsiveness in neurons postsynaptic to these neurons, analogous to
observations in vertebrates (36). Determining whether the failure of
pka-RIIEP(2)2162 to sensitize results from deficient
cAMP signaling in the aminergic neurons themselves or in neurons
postsynaptic to these neurons will be addressed by further studies.
Mice lacking RII show a distinct phenotype of sensitizing more
intensely than wild type mice to repeated amphetamine exposures (14).
This observation clearly indicates an involvement for modulated PKA
signaling in sensitization, but due to the complications of redundant
genes and compensation mentioned above, more precise interpretations
are not possible. Our results in flies indicate, however, involvement
of PKA-RII in sensitization in a manner that any potential compensation
by the remaining pka-RI gene cannot overcome.
Since pka-RIIEP(2)2162 lacks PKA-RII protein, the
major gene product that mediates proper subcellular localization of PKA
activity in cells, it is possible that abnormal redistribution of
subcellular localization of PKA activity in the
pka-RIIEP(2)2162 could be partly responsible for the
abnormal responsiveness to cocaine. Potentially relevant is the recent
report that dopaminergic modulation of a voltage-gated
Na+ current which is involved in cocaine sensitization in
rat hippocampal neurons requires PKAII anchoring (44, 45).
Resistance of pka-RIIEP(2)2162 to Ethanol--
We studied
responses of pka-RIIEP(2)2162 to ethanol since a
previous study indicates involvement of cAMP signaling in modulating
sensitivity of Drosophila to ethanol (11). Mutations in
amnesiac, rutabaga, and pka-C1, each
thought to decrease cAMP levels or signaling, all show hypersensitivity
to ethanol. Furthermore, the hypersensitivity of amn can be
rescued by feeding of forskolin, an activator of adenylate cyclase
(11). However, this study also indicated some complexity in the
signaling pathways involved in these responses, since double mutant
combinations of cAMP activating and repressing mutants gave paradoxical
responses. This complexity is most readily explained by proposing the
existence of neuronal signaling pathways, in which given neurons can
positively or negatively affect activity of other neurons in the circuitry.
In the present study, we found that pka-RIIEP(2)2162
flies show robust resistance to ethanol. This is most simply
interpreted as indicating that responses to cocaine and ethanol are
mediated through a common PKA-dependent signaling step.
However, further study will be required to confirm this interpretation.
Determination of whether the resistance of
pka-RIIEP(2)2162 to ethanol is consistent with the
previous observations of ethanol hypersensitivity of cAMP signaling
deficient strains of Drosophila (11) is complicated. Recall
that pka-RIIEP(2)2162 shows both an increased basal
level of PKA as assayed in the absence of cAMP and a reduced level in
the presence of cAMP, yielding overall reduced induction of PKA
activity by cAMP. Thus, the simplest explanation is that these flies
should be hypersensitive to ethanol since they show reduced
cAMP-inducible signaling. However, this simple explanation may not hold
for several reasons. First, flies with selectively altered PKAII
signaling may show very different responses to ethanol than flies with
overall reductions in PKA signaling. Since the cellular patterns of
PKAI and -II expression and signaling have not been examined in
Drosophila, it is possible that they regulate complementary
or opposing neural circuits. Second, different types of developmental
compensation may be possible in Drosophila strains with
general defects in PKA signaling as opposed to selective defects in the
PKAII pathway. Further studies will clearly be required to elucidate
these complexities.
Defects in Ovarian Development of pka-RIIEP(2)2162--
A
multinucleate nurse cell phenotype has been observed previously in
ovaries from strains carrying mutations in pka-C1, encoding a PKA catalytic subunit (23, 34). pka-C1 interacts
genetically with cut, a gene encoding a homeodomain nuclear
protein, as a dominant enhancer of the multinucleate cell phenotype in
early oogenesis (46). As expected, we found that
pka-RIIEP(2)2162 flies show a multinucleate cell
phenotype similar to that seen in pka-C1 and cut.
However, pka-RIIEP(2)2162 also shows some unique
phenotypes, such as the loss of ring canals from fused nurse cells and
extra posterior follicle epithelial layers, suggesting that PKA-RII
regulatory subunits exert more complicated functions than simply
regulating catalytic activity of C subunits. One possible explanation
is that the subcellular localization of PKA activity, which would
expect to be disrupted in pka-RIIEP(2)2162 flies,
might be required for normal oogenesis. Given that PKA-RII is the major
mediator of subcellular localization of PKA activity through the
interaction with AKAPs (47), it will be interesting to study the role
of AKAPs in ovarian development.
Precisely what role(s) PKA signaling plays during the formation and
maturation of ovarian follicles is not clear. Other signaling pathways,
including Notch/Delta (48-50), Egfr (51), and
hedgehog (52), have also been shown genetically to be
required for these processes of oogenesis, and it is likely from the
various genetic interactions observed that these pathways overlap or
intersect in complex ways. For example, based on loss-of-function
mutant interactions, PKA signaling may regulate early oogenesis
downstream of cut gene function; however, loss-of-function
cut mutations also suppress Notch
loss-of-function ovary phenotypes (46), suggesting a link between these
two signaling pathways.
Locomotor Arrhythmicity of
pka-RIIEP(2)2162--
Pharmacological and genetic studies
suggest that cAMP signaling plays a prominent role in the manifestation
of circadian rhythms in both vertebrate and invertebrate model systems
(9, 53-57). In Drosophila, the analyses of
pka-C1 and dunce show that the cAMP signaling
likely participates in the light-resetting mechanism (57) and/or
locomotor-output pathways (9). Consistent with these observations,
pka-RIIEP(2)2162 shows obvious locomotor
arrhythmicity. However, the lack of PKAII does not completely abolish
the free-running rhythm in pka-RIIEP(2)2162 flies,
since a weak rhythm lasts at least for the 2-3 days in DD conditions.
This observation is similar to the phenotype of pka-C1
flies, which show obvious locomotor arrhythmicity but normal period protein oscillation (9). Our observation supports the view that PKA is involved in the locomotor output pathway and indicates
that PKAII is a major player in this process.
 |
ACKNOWLEDGEMENTS |
We thank the Berkeley Drosophila
Genome Center for the line EP(2)2162 and for web-based computer
resources that allowed its identification. We thank Uli Muller for
generous and useful experimental advice and Stanley McKnight and the
members of our laboratories for helpful comments on the manuscript. We
thank Dan Kalderon for the generous gift of anti-RII antibodies.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM/DA 27318 (to J. H.) and National Science Foundation Grant IBN-9723350 (to C. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF274008.
To whom correspondence should be addressed: Dept. of Biology,
Gilmer Hall, University of Virginia, Charlottesville, VA 22903. Tel.:
804-982-5608; Fax: 804-982-5626; E-mail: jh6u@virginia.edu.
Published, JBC Papers in Press, April 25, 2000, DOI 10.1074/jbc.M002460200
 |
ABBREVIATIONS |
The abbreviations used are:
PKA, cAMP-dependent protein kinase;
PKAII, type II
cAMP-dependent protein kinase;
PKA-RII, type II PKA
regulatory subunit;
AKAPs, protein kinase A-anchoring proteins;
BDGP, Berkeley Drosophila Genome Project.
 |
REFERENCES |
| 1.
|
Schwartz, J. H.,
and Greenberg, S. M.
(1987)
Annu. Rev. Neurosci.
10,
459-476
|
| 2.
|
Yin, J. C.,
Wallach, J. S.,
Del Vecchio, M.,
Wilder, E. L.,
Zhou, H.,
Quinn, W. G.,
and Tully, T.
(1994)
Cell
79,
49-58
|
| 3.
|
Davis, R. L.,
Cherry, J.,
Dauwalder, B.,
Han, P. L.,
and Skoulakis, E.
(1995)
Mol. Cell. Biochem.
149-150,
271-278
|
| 4.
|
Connolly, J. B.,
Roberts, I. J.,
Armstrong, J. D.,
Kaiser, K.,
Forte, M.,
Tully, T.,
and O'Kane, C. J.
(1996)
Science
274,
2104-2107
|
| 5.
|
Goodwin, S. F.,
Del Vecchio, M.,
Velinzon, K.,
Hogel, C.,
Russell, S. R.,
Tully, T.,
and Kaiser, K.
(1997)
J. Neurosci.
17,
8817-8827
|
| 6.
|
Mayford, M.,
and Kandel, E. R.
(1999)
Trends Genet.
15,
463-470
|
| 7.
|
Davis, G. W.,
DiAntonio, A.,
Petersen, S. A.,
and Goodman, C. S.
(1998)
Neuron
20,
305-315
|
| 8.
|
Pothos, E. N.,
Przedborski, S.,
Davila, V.,
Schmitz, Y.,
and Sulzer, D.
(1998)
J. Neurosci.
18,
5575-5585
|
| 9.
|
Majercak, J.,
Kalderon, D.,
and Edery, I.
(1997)
Mol. Cell. Biol.
17,
5915-5922
|
| 10.
|
Chyb, S.,
Hevers, W.,
Forte, M.,
Wolfgang, W. J.,
Selinger, Z.,
and Hardie, R. C.
(1999)
J. Neurosci.
19,
8799-8807
|
| 11.
|
Moore, M. S.,
DeZazzo, J.,
Luk, A. Y.,
Tully, T.,
Singh, C. M.,
and Heberlein, U.
(1998)
Cell
93,
997-1007
|
| 12.
|
Pandey, S. C.
(1998)
Mol. Neurobiol.
17,
1-15
|
| 13.
|
Nestler, E. J.,
and Aghajanian, G. K.
(1997)
Science
278,
58-63
|
| 14.
|
Brandon, E. P.,
Logue, S. F.,
Adams, M. R.,
Qi, M.,
Sullivan, S. P.,
Matsumoto, A. M.,
Dorsa, D. M.,
Wehner, J. M.,
McKnight, G. S.,
and Idzerda, R. L.
(1998)
J. Neurosci.
18,
3639-3649
|
| 15.
|
Taylor, S. S.,
Buechler, J. A.,
and Yonemoto, W.
(1990)
Annu. Rev. Biochem.
59,
971-1005
|
| 16.
|
Scott, J. D.
(1991)
Pharmacol. Ther.
50,
123-145
|
| 17.
|
Carre, I. A.,
and Edmunds, L. N., Jr.
(1992)
J. Biol. Chem.
267,
2135-2137
|
| 18.
|
Burton, K. A.,
Johnson, B. D.,
Hausken, Z. E.,
Westenbroek, R. E.,
Idzerda, R. L.,
Scheuer, T.,
Scott, J. D.,
Catterall, W. A.,
and McKnight, G. S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11067-11072
|
| 19.
|
Cadd, G.,
and McKnight, G. S.
(1989)
Neuron
3,
71-79
|
| 20.
|
Kalderon, D.,
and Rubin, G. M.
(1988)
Genes Dev.
2,
1539-1556
|
| 21.
|
Foster, J. L.,
Guttman, J. J.,
Hall, L. M.,
and Rosen, O. M.
(1984)
J. Biol. Chem.
259,
13049-13055
|
| 22.
|
Muller, U.
(1997)
J. Neurobiol.
33,
33-44
|
| 23.
|
Lane, M. E.,
and Kalderon, D.
(1993)
Genes Dev.
7,
1229-1243
|
| 24.
|
Perrimon, N.
(1996)
Cell
86,
513-516
|
| 25.
|
Amieux, P. S.,
Cummings, D. E.,
Motamed, K.,
Brandon, E. P.,
Wailes, L. A.,
Le, K.,
Idzerda, R. L.,
and McKnight, G. S.
(1997)
J. Biol. Chem.
272,
3993-3998
|
| 26.
|
Rorth, P.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12418-12422
|
| 27.
|
Kumon, A.,
Nishiyama, K.,
Yamamura, H.,
and Nishizuka, Y.
(1972)
J. Biol. Chem.
247,
3726-3735
|
| 28.
|
McClung, C.,
and Hirsh, J.
(1998)
Curr. Biol.
8,
109-112
|
| 29.
|
Rosen, O. M.,
and Erlichman, J.
(1975)
J. Biol. Chem.
250,
7788-7794
|
| 30.
|
Inoue, H.,
and Yoshioka, T.
(1997)
Biochem. Biophys. Res. Commun.
235,
223-226
|
| 31.
|
Rangel-Aldao, R.,
and Rosen, O. M.
(1976)
J. Biol. Chem.
251,
7526-7529
|
| 32.
|
Kuo, J. F.,
and Greengard, P.
(1969)
Proc. Natl. Acad. Sci. U. S. A.
64,
1349-1355
|
| 33.
|
Takio, K.,
Smith, S. B.,
Krebs, E. G.,
Walsh, K. A.,
and Titani, K.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
2544-2548
|
| 34.
|
Lane, M. E.,
and Kalderon, D.
(1995)
Mech. Dev.
49,
191-200
|
| 35.
|
Kalivas, P. W.
(1995)
in
The Neurobiology of Cocaine: Cellular and Molecular Mechanisms
(Hammer, Ronald P., Jr., ed)
, pp. 81-98, CRC Press, Inc., Boca Raton, FL
|
| 36.
|
White, F. J.,
Hu, X.-T.,
Henry, D. J.,
and Zhang, S.-F.
(1995)
in
The Neurobiology of Cocaine: Cellular and Molecular Mechanisms
(Hammer, Ronald P., Jr., ed)
, pp. 91-119, CRC Press, Inc., Boca Raton, FL
|
| 37.
|
Pierce, R. C.,
and Kalivas, P. W.
(1997)
Brain Res. Rev.
25,
192-216
|
| 38.
|
Terwilliger, R. Z.,
Beitner-Johnson, D.,
Sevarino, K. A.,
Crain, S. M.,
and Nestler, E. J.
(1991)
Brain Res.
548,
100-110
|
| 39.
|
Pierce, R. C.,
Born, B.,
Adams, M.,
and Kalivas, P. W.
(1996)
J. Pharmacol. Exp. Ther.
278,
384-392
|
| 40.
|
O'Hara, C. M.,
Uhland-Smith, A.,
O'Malley, K. L.,
and Todd, R. D.
(1996)
J. Pharmacol. Exp. Ther.
277,
186-192
|
| 41.
|
Jones, S. R.,
Gainetdinov, R. R.,
Jaber, M.,
Giros, B.,
Wightman, R. M.,
and Caron, M. G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4029-4034
|
| 42.
|
Li, H.,
Chaney, S.,
Forte, M.,
and Hirsh, J.
(2000)
Curr. Biol.
10,
211-214
|
| 43.
|
Andretic, R.,
Chaney, S.,
and Hirsh, J.
(1999)
Science
285,
1066-1068
|
| 44.
|
Cantrell, A. R.,
Smith, R. D.,
Goldin, A. L.,
Scheuer, T.,
and Catterall, W. A.
(1997)
J. Neurosci.
17,
7330-7338
|
| 45.
|
Cantrell, A. R.,
Scheuer, T.,
and Catterall, W. A.
(1999)
J. Neurosci.
19,
5301-5310
|
| 46.
|
Jackson, S. M.,
and Blochlinger, K.
(1997)
Development
124,
3663-3672
|
| 47.
|
Colledge, M.,
and Scott, J. D.
(1999)
Trends Cell Biol.
9,
216-221
|
| 48.
|
Ruohola, H.,
Bremer, K. A.,
Baker, D.,
Swedlow, J. R.,
Jan, L. Y.,
and Jan, Y. N.
(1991)
Cell
66,
433-449
|
| 49.
|
Xu, T.,
Caron, L. A.,
Fehon, R. G.,
and Artavanis-Tsakonas, S.
(1992)
Development
115,
913-922
|
| 50.
|
Bender, L. B.,
Kooh, P. J.,
and Muskavitch, M. A.
(1993)
Genetics
133,
967-978
|
| 51.
|
Goode, S.,
Wright, D.,
and Mahowald, A. P.
(1992)
Development
116,
177-192
|
| 52.
|
Forbes, A. J.,
Lin, H.,
Ingham, P. W.,
and Spradling, A. C.
(1996)
Development
122,
1125-1135
|
| 53.
|
Eskin, A.,
Corrent, G.,
Lin, C. Y.,
and McAdoo, D. J.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
660-664
|
| 54.
|
Eskin, A.,
and Takahashi, J. S.
(1983)
Science
220,
82-84
|
| 55.
|
Nikaido, S. S.,
and Takahashi, J. S.
(1989)
Neuron
3,
609-619
|
| 56.
|
Carre, I. A.,
and Edmunds, L. N., Jr.
(1993)
J. Cell Sci.
104,
1163-1173
|
| 57.
|
Levine, J. D.,
Casey, C. I.,
Kalderon, D. D.,
and Jackson, F. R.
(1994)
Neuron
13,
967-974
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Schwaerzel, A. Jaeckel, and U. Mueller
Signaling at A-Kinase Anchoring Proteins Organizes Anesthesia-Sensitive Memory in Drosophila
J. Neurosci.,
January 31, 2007;
27(5):
1229 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Taghert and O. T. Shafer
Mechanisms of Clock Output in the Drosophila Circadian Pacemaker System
J Biol Rhythms,
December 1, 2006;
21(6):
445 - 457.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Collier, K. Suyama, J. H. Anderson, and M. P. Scott
Drosophila Costal1 Mutations Are Alleles of Protein Kinase A That Modulate Hedgehog Signaling
Genetics,
June 1, 2004;
167(2):
783 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yoshida, H-A. J. Muller, A. Wodarz, and A. Ephrussi
PKA-R1 spatially restricts Oskar expression for Drosophila embryonic patterning
Development,
March 15, 2004;
131(6):
1401 - 1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Terman and A. L. Kolodkin
Nervy Links Protein Kinase A to Plexin-Mediated Semaphorin Repulsion
Science,
February 20, 2004;
303(5661):
1204 - 1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. W. Wolf, A. R. Rodan, L. T.-Y. Tsai, and U. Heberlein
High-Resolution Analysis of Ethanol-Induced Locomotor Stimulation in Drosophila
J. Neurosci.,
December 15, 2002;
22(24):
11035 - 11044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Rodan, J. A. Kiger Jr, and U. Heberlein
Functional Dissection of Neuroanatomical Loci Regulating Ethanol Sensitivity in Drosophila
J. Neurosci.,
November 1, 2002;
22(21):
9490 - 9501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Berke and C.-F. Wu
Regional Calcium Regulation within Cultured Drosophila Neurons: Effects of Altered cAMP Metabolism by the Learning Mutations dunce and rutabaga
J. Neurosci.,
June 1, 2002;
22(11):
4437 - 4447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Constantinescu, A. S. Gordon, and I. Diamond
cAMP-dependent Protein Kinase Types I and II Differentially Regulate cAMP Response Element-mediated Gene Expression. IMPLICATIONS FOR NEURONAL RESPONSES TO ETHANOL
J. Biol. Chem.,
May 17, 2002;
277(21):
18810 - 18816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Jackson and C. A. Berg
An A-kinase anchoring protein is required for Protein kinase A regulatory subunit localization and morphology of actin structures during oogenesis in Drosophila
Development,
January 10, 2002;
129(19):
4423 - 4433.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|